We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr Atkins is the CEO of Congenica, a leading provider of clinical decision support software used for interpreting genome data from patients with rare diseases. Congenica is a Cambridge based spinout from The Sanger Institute. David has 25 years’ experience as a global leader in a broad range of diagnostics, medical devices and healthcare businesses such as Johnson & Johnson, Danaher and Synevo. David has a PhD from University of East Anglia, UK and MBA from Columbia University, USA
This speaker's sessions: